1. Home
  2. EVGN vs XBIO Comparison

EVGN vs XBIO Comparison

Compare EVGN & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$0.86

Market Cap

9.1M

Sector

Industrials

ML Signal

HOLD

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$3.03

Market Cap

7.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVGN
XBIO
Founded
1999
N/A
Country
Israel
United States
Employees
N/A
2
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1M
7.5M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
EVGN
XBIO
Price
$0.86
$3.03
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$3.50
N/A
AVG Volume (30 Days)
131.3K
24.3K
Earning Date
03-05-2026
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$2.81
Revenue Next Year
$73.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$1.90
52 Week High
$2.42
$13.93

Technical Indicators

Market Signals
Indicator
EVGN
XBIO
Relative Strength Index (RSI) 45.08 60.81
Support Level $0.81 $2.64
Resistance Level $1.23 $3.12
Average True Range (ATR) 0.06 0.25
MACD 0.01 0.06
Stochastic Oscillator 56.57 60.47

Price Performance

Historical Comparison
EVGN
XBIO

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Share on Social Networks: